Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Novavax Reports Initiation of PREVENT-19 Phase 3 Trial of COVID-19 Vaccine in U.S. and Mexico
Novavax, Inc. (NASDAQ: NVAX) announced the initiation of PREVENT-19, pivotal phase 3 study within the United States and Mexico to determinate the efficacy, immunogenicity and safety of NVX-CoV2373, the...